Model & Data
Published governance documentation for the review-context configurations and the structured data they operate on.
Version 1.4Last updated 2026-07-30
Purpose
- Intended use
- Organise de-identified medication-review context so a licensed pharmacist can review, edit and approve a documented assessment.
- Scope
- Dyslipidemia and statin-related medication reviews conducted by a reviewing pharmacist.
Intended workflow
- Entry point
- Structured intake completed by the reviewing pharmacist.
- Processing
- Review context is organised, linked to source material and summarised.
- Exit point
- A pharmacist-edited, pharmacist-approved review document.
Inputs
- Structured fields
- Review type, medication context, tolerance context, co-medication context, laboratory context.
- Excluded inputs
- No names, addresses, dates of birth, health-card numbers or free identifiers.
Outputs
- Review summary
- A structured summary of the recorded review context.
- Factor view
- Relative emphasis across the recorded review factors.
- Not produced
- No autonomous dosing, prescription or patient-specific recommendation.
Human oversight
- Editing
- Every generated section is editable before it can move forward.
- Approval
- A licensed pharmacist completes the approval checklist and signs off.
- Traceability
- Each state change is recorded in the audit log.
Version
- Current version
- 1.4
- Released
- 2026-07-30
- Owner
- Rediscover Dosage — Technology
Limitations
- Therapeutic scope
- Limited to dyslipidemia and statin-related review context.
- Decision scope
- Produces review context only; clinical decisions remain with the pharmacist.
- Data scope
- Operates on de-identified structured fields only.
Change history
- 1.4 — 2026-07-30
- Factor-emphasis presentation aligned across model configurations.
- 1.3 — 2026-06-12
- Information-gap handling extended to the approval checklist.
- 1.2 — 2026-05-02
- Source-reference linking added to review factors.